Abstract

Abstract The crystal structures are reported of N-[2-(1-benzenesulfonyl-1H-pyrazol-3-yl)-6-methyl-phenyl]-benzenesulfonamide, 1, and N-[2-(1-toluene-4-sulfonyl-1H-pyrazol-3-yl)-6-methyl-phenyl]-benzenesulfonamide, 2: two compounds used in a recently reported antileishmania study. The crystallographic study reveals significant differences in the conformations adopted by molecules of 1 compared to those adopted by the three independent molecules of 2 in the solid state. The conformation differences between molecules of 1, on one hand, and the three molecules of 2, on the other, are not driven by steric effects within the molecular arrangements. If molecules 2 adopted the molecular conformation found for 1, severe steric interference would occur in the chains and other aggregates generated from the intermolecular contacts. As all the intermolecular interactions are of a weak nature, it is unlikely that aggregation would survive in dilute aqueous media, and hence the steric constraints on the conformations adopted in the solid state would not be in place in solution. Thus the difference in the solid state conformations offers no light on the greater activity of compound 1 compared to that of compound 2 in the antileishmania study in aqueous media.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.